Svensk version All offices All contacts Home About Sobi Patients Research Partnering Healthcare Professionals Investors & Media Careers Products Sobi has a diversified and growth-oriented commercial product portfolio within three business lines. To products Sobi@ISTH2015 Sobi attended the ISTH 2015 conference in Toronto, Canada. The ISTH video blog was broadcasted daily in order to share learnings. Both haemophilia specialists and patient representatives were interviewed. Go to SobiPlay.com Annual General Meeting 2015 The Annual General Meeting in Swedish Orphan Biovitrum AB (publ), Reg. No. 556038-9321, was held on Tuesday, June 30, 2015 in Wallenbergsalen, the Royal Swedish Academy of Engineering Sciences (IVA), Grev Turegatan 16, Stockholm, Sweden Read more Presentation of Sobi's Interim Report April - June 2015 16 July, 2015 Sobi's Report for the first quarter was published - Revenues for the quarter totalled SEK 764 M (663), an increase of 15 per cent. Interim Report January - June 2015 Annual Report 2014 online version Annual Report 2014 pdf Financial report archive Share Price SEK110.40 SEK 0.00 Procent 0.00% Volume: 0 Ticker: SOBI List: SSE Large More About the Share News Reports Show: All News Press releases New number of shares and votes in Swedish Orphan Biovitrum AB 2015-09-30 08:00 in Press releases Sobi CEO invests in 2015 LTI programme and divests a portion of incentive shares 2015-09-29 08:00 in Press releases Biogen and Sobi receive positive opinion from CHMP for Elocta(TM) (rFVIIIFc) for the tr... 2015-09-25 13:30 in Press releases Swedish Orphan Biovitrum AB (publ) : The board of directors exercises authorisation for... 2015-09-11 08:30 in Press releases More news Contact Swedish Orphan Biovitrum AB (publ) SE-112 76 Stockholm, Sweden Phone: +46 8 697 20 00 Reg.No. 556038-9321 © Swedish Orphan Biovitrum AB, 2013 Quick Links Terms of use & cookies All contacts Follow us Press releases News Financial reports